Lubiprostone in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled, phase 2a trial
Takaomi Kessoku, Kento Imajo, Takashi Kobayashi, Anna Ozaki, Michihiro Iwaki, Yasushi Honda, Takayuki Kato, Yuji Ogawa, Wataru Tomeno, Shingo Kato, Takuma Higurashi, Masato Yoneda, Hiroyuki Kirikoshi, Kazumi Kubota, Masataka Taguri, Takeharu Yamanaka, Haruki Usuda, Koichiro Wada, Noritoshi Kobayashi, Satoru Saito, Atsushi Nakajima
Topics & Concepts
LubiprostoneMedicineInternal medicinePlaceboGastroenterologyLaxativeConstipationClinical endpointAlcoholic liver diseaseFatty liverClinical trialChronic constipationDiseaseCirrhosisPathologyAlternative medicineLiver Disease Diagnosis and TreatmentGastrointestinal motility and disordersLiver Disease and Transplantation